Navigation Links
Amsterdam Molecular Therapeutics Initiates Program for Late Stage Liver Cirrhosis and Reports Strong Progress in AMT-011 With Trial Fully Recruited and European and US Submission On Track for First Half of 2008
Date:11/27/2007

of AAV engineered to carry IGF-1 were sufficient to interfere with, or even reverse fibrosis and achieve a long term effect. AAV vectors constitute the gene therapy platform of choice of Amsterdam Molecular Therapeutics.

A pilot clinical trial conducted by investigators in Pamplona, Spain and Groningen, The Netherlands in a small number of cirrhotic patients supports the importance of IGF-1 in treating cirrhosis - both an increased serum albumin and improved energy metabolism were achieved as a result of (subcutaneous) IGF-I protein administration. Because of the short half-life of IGF-1, a treatment based on the subcutaneous administration of recombinant IGF-I would require almost constant infusion and is not considered practical. The gene-therapy-mediated induction of IGF-I expression bypasses this disadvantage and shows long-term effect, as the animal studies at CIMA have shown. Clinical studies will need to confirm the long-term safety and efficacy in men.

Ronald Lorijn, CEO of AMT, said, "We are very pleased with our agreement with CIMA, which gives us access to programs that are already well-advanced and that have tremendous potential. Our technology platform seems ideally suited to develop IGF-I for the treatment of liver cirrhosis, a very serious disorder, which not only causes great human suffering, but also comes at a very high cost for society. AMT is fully dedicated and equipped to add this new program to its product pipeline and plans to start the necessary pre-clinical studies including a full toxicology program next year. We are confident to continue to leverage our close relationship with Digna and CIMA to fill our pipeline with promising products that address unmet medical needs."

Clinical Program AMT-011

The clinical development of AMT's lead product AMT-011 for the treatment of Lipoprotein Lipase Deficiency is proceeding according to plan. All patients have been recruited in the Canadian study. A total of 6 patients ha
'/>"/>

SOURCE Amsterdam Molecular Therapeutics B.V
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Chiltern to Participate at the Partnerships in Clinical Trials Conference in Amsterdam
2. A new molecular zip code, and a new drug target for Huntingtons disease
3. New knock-out gene model provides molecular clues to breast cancer
4. Molecular probe paints cancer cells in living animals, Stanford researchers find
5. Story ideas from molecular & cellular proteomics
6. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
7. SNM seeks novel approaches to molecular imaging to showcase at annual meeting
8. Molecular fingerprint of breast-cancer drug resistance can predict response to treatment
9. Molecular profiling can accurately predict survival in colon cancer patients
10. Xceed Molecular Names Fran Tuttle to Its Board of Trustees
11. Virginia G. Piper Charitable Trust and Flinn Foundation launch molecular diagnostics initiative
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... Maintaining proper oral hygiene is just as important for ... In recent years, many different products have become available to ... white. Royal Flush Havanese shares with readers some ... while choosing the top products that are the most effective. ... in a dog’s mouth, causing bad breath. This can also ...
(Date:7/23/2014)... New York, NY (PRWEB) July 23, 2014 ... to 2 billion dollars by the year 2020, according ... the skin are among the top sellers in the ... products. The best wrinkle cream under $100 is now ... is meant to help a first-time or experienced shopper ...
(Date:7/23/2014)... The puffiness that can appear underneath ... according to a new guide published at the CherryNews.com ... the U.S. is now available for men and women ... guide that is now published is meant to provide ... puffiness. While surgical techniques are available, there are all-natural ...
(Date:7/23/2014)... scientist from the University of Exeter has developed ... diagnosing a frequently fatal lung disease which attacks ... bone marrow transplant recipients. , The lateral-flow device ... pulmonary aspergillosis, a notoriously difficult to diagnose disease ... , Invasive aspergillosis is a leading ...
(Date:7/23/2014)... Randy Dotinga HealthDay Reporter ... A powerful drug combo may not be as effective ... on human cells suggests that one of the medications ... this study,s findings aren,t definitive, and there,s still hope ... and lumacaftor, according to the study,s senior author. ...
Breaking Medicine News(10 mins):Health News:Royal Flush Havanese Reviews Tips on Proper Dental Care For Canines 2Health News:Royal Flush Havanese Reviews Tips on Proper Dental Care For Canines 3Health News:Best Wrinkle Cream Under $100 Reviewed at Top News Website Online 2Health News:Puffy Eyes Serum Explored in Complimentary Guide Released at Consumer News Website 2Health News:New device detects deadly lung disease 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 3
... comeback. Recently published case series have shown encouraging ... treatment-resistant obsessive-compulsive disorder, depressive disorders, and Tourette syndrome. ... International , authors Jens Kuhn (University of Cologne) ... Cologne) and their co-authors provide an introduction to ...
... ... America , ... MD (Vocus) March 2, 2010 -- As Maryland Gov. Martin O’Malley proposes cutting $123 million ... year 2010, a new study by Dr. Todd Eberly, assistant professor of political science and ...
... ... for the Cure® events across the country. , ... Collegedale, TN (Vocus) March 4, 2010 -- Sunbelt ® is pleased to announce ... , , , , ,“The Sunbelt employees who volunteered and participated in last year’s events had ...
... , ... ... , ... , , ...
... ... ... ... ...
... ... Month, Independence-based preventive health screening provider offers discounted FDA-approved home tests kits for colorectal ... Independence, ... kits for colorectal cancer for a discounted price of $15. Neighborhood screenings can ...
Cached Medicine News:Health News:Proposed Medicaid Cuts Threatens Health Care Access for 400,000 Maryland Children 2Health News:Proposed Medicaid Cuts Threatens Health Care Access for 400,000 Maryland Children 3Health News:Sunbelt Announces Renewed Commitment to Breast Cancer Awareness 2Health News:KID HEALTHY Childhood Obesity Prevention Program Reflects First Lady's Focus 2Health News:KID HEALTHY Childhood Obesity Prevention Program Reflects First Lady's Focus 3Health News:KID HEALTHY Childhood Obesity Prevention Program Reflects First Lady's Focus 4Health News:KID HEALTHY Childhood Obesity Prevention Program Reflects First Lady's Focus 5Health News:Essilor - 2009 Financial Results 2Health News:Essilor - 2009 Financial Results 3Health News:Essilor - 2009 Financial Results 4Health News:Essilor - 2009 Financial Results 5Health News:Essilor - 2009 Financial Results 6Health News:Essilor - 2009 Financial Results 7Health News:Essilor - 2009 Financial Results 8Health News:Essilor - 2009 Financial Results 9Health News:Essilor - 2009 Financial Results 10Health News:Essilor - 2009 Financial Results 11Health News:Essilor - 2009 Financial Results 12Health News:Essilor - 2009 Financial Results 13Health News:Essilor - 2009 Financial Results 14Health News:Essilor - 2009 Financial Results 15Health News:Essilor - 2009 Financial Results 16Health News:Essilor - 2009 Financial Results 17Health News:Essilor - 2009 Financial Results 18Health News:Essilor - 2009 Financial Results 19Health News:Essilor - 2009 Financial Results 20Health News:Life Line Screening Offers Special Pricing on Colorectal Home Test Kits in Honor of National Colorectal Cancer Month 2
(Date:7/23/2014)... NORWALK, Conn. , July 23, 2014 ... NeurologyTimes.com – a new online community and information ... them better manage and treat their patients with ... conditions, coupled with an aging population, necessitates greater access ... specific disorders.  Key statistics on neurological conditions include: ...
(Date:7/23/2014)... , July 23, 2014 Pharmavite LLC announced ... chief customer officer effective immediately. Toll recently served as ... and marketing, category management, private label and sales administration ... his new global role, Toll will expand his responsibilities ... planning. "Toll,s appointment to chief customer officer ...
(Date:7/23/2014)... DUBLIN , July 23, 2014 ... addition of the "Global Electrophysiology Ablation Catheters ... http://photos.prnewswire.com/prnh/20130307/600769 ... to remove or destroy faulty electrical pathways from ... rhythms (also known as cardiac arrhythmias). Cardiac arrhythmias ...
Breaking Medicine Technology:UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 2Global Electrophysiology Ablation Catheters Market 2014-2018: Key Vendors are Boston Scientific, Johnson & Johnson, Medtronic and St. Jude Medical 3
... , , MOUNTAIN VIEW, Calif., Dec. 29 ... developing innovative, next-generation medical therapies to address unmet needs in ... Drug Application (NDA) has been submitted to the U.S. Food ... drug for the treatment of obesity, including weight loss and ...
... , , REDWOOD CITY, Calif., Dec. 28 Codexis, ... Form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating ... stock. The shares of common stock to be sold in ... certain of its stockholders. , Credit Suisse Securities (USA) LLC and ...
Cached Medicine Technology:VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity 2VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity 3VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity 4VIVUS Submits Qnexa(R) New Drug Application to the FDA for the Treatment of Obesity 5Codexis, Inc. Files Registration Statement for Proposed Initial Public Offering 2
Operating microscope with motorized zoom and variable focus up to 405 mm....
... Opmi Vario/NC33 system microscope provides surgeons with ... These microscopes are ideal for many minimally ... Ergonomically designed at every point of contact. ... in a surgical microscope allows intuitive user ...
Curved left, Hardy Curettes, bayonet, working distance 120 mm, total length 241 mm....
Toothed pituitary rongeur. Straight....
Medicine Products: